Basics Carisma Therapeutics, Inc. IPO Date: February 3, 2014 Sector: Healthcare Industry: Biotech Market Cap: $6.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.93% Avg Daily Range (30 D): $0.02 | 9.78% Avg Daily Range (90 D): $0.02 | 7.26% Institutional Daily Volume Avg Daily Volume: 1.86M Avg Daily Volume (30 D): 1.69M Avg Daily Volume (90 D): 5.57M Trade Size Avg Trade Size (Sh.): 417 Avg Trade Size (Sh.) (30 D): 787 Avg Trade Size (Sh.) (90 D): 587 Institutional Trades Total Inst.Trades: 13 Avg Inst. Trade: $3.26M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .6M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.58M Avg Closing Trade (30 D): $3.25M Avg Closing Trade (90 D): $3.25M Avg Closing Volume: 784.55K     News Jul 26, 2025 @ 5:47 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 16, 2025 @ 3:32 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire Jul 15, 2025 @ 12:31 AM $HAREHOLDER ALERT: The M&A Class Action Firm Launc... Source: Juan Monteverde Jul 5, 2025 @ 1:48 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 1, 2025 @ 10:18 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.23 $-.22 $-.42 Diluted EPS $-.23 $-.22 $-.42 Revenue $ M $ 3.7M $ 3.6M Gross Profit $ $ $ Net Income / Loss $ -9.77M $ -9.27M $ -17.64M Operating Income / Loss $ -5.78M $ -9.33M $ -17.86M Cost of Revenue $ $ $ Net Cash Flow $ -5.74M $ -10.17M $ -8.97M PE Ratio     Splits Mar 08, 2023:   2:1